COCP (Cocrystal Pharma) GF Score: 25/100 (As of Jun. 28, 2026) — 32% Below Median


COCP Cocrystal Pharma Inc COCP
25 GF Score
Price $1.04
! 3 Warning Signs
View Full Analysis

What is Cocrystal Pharma GF Score?

Cocrystal Pharma COCP +0.99% 25 GF Score is 25 as of Jun. 28, 2026, which is 32% below its 10-year median of 37.00. GuruFocus rates COCP with a GF Score™ of 25/100. The stock has 3 warning signs investors should review.

Cocrystal Pharma has the GF Score of 25, which implies that the company might have Worst future performance potential, or not enough data.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 3/10
2. Profitability Rank : 0/10
3. Growth Rank : 0/10
4. GF Value Rank : 2/10
5. Momentum Rank : 7/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Cocrystal Pharma might have Worst future performance potential, or not enough data.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Cocrystal Pharma  (NAS:COCP) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

Cocrystal Pharma GF Score Related Terms

COCP vs OSRH, CVKD, LEXX: GF Score Comparison

For the Biotechnology subindustry, Cocrystal Pharma's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cocrystal Pharma GF Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cocrystal Pharma's GF Score distribution charts can be found below:

* The bar in red indicates where Cocrystal Pharma's GF Score falls into.


COCP
25GF Score
Cocrystal Pharma Inc COCP
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 25 mean?
Cocrystal Pharma (COCP) has a GF Score of 25 as of Jun. 28, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Cocrystal Pharma and its competitors. This is 32% below median its historical median of 37.00. Over the past decade, Cocrystal Pharma's GF Score has ranged from 20.00 to 61.00.
Is Cocrystal Pharma's GF Score too high?
Cocrystal Pharma's current GF Score of 25 is 32% below median its 10-year median of 37.00. Over the past 10 years, this metric has ranged from a low of 20.00 to a high of 61.00. Overall, Cocrystal Pharma has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Cocrystal Pharma's GF Score compare to OSRH and CVKD?
Cocrystal Pharma's GF Score of 25 can be compared against companies in the Biotechnology industry. Historically, Cocrystal Pharma's own GF Score has ranged from 20.00 to 61.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Biotechnology company?
A good GF Score depends on the Biotechnology industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Cocrystal Pharma and its competitors. Cocrystal Pharma's current GF Score is 25, which is 32% below median its own 10-year median of 37.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cocrystal Pharma stock overvalued right now?
Cocrystal Pharma (COCP) has a current GF Score of 25. The current GF Score is 25, which is 32% below median its 10-year median of 37.00. Cocrystal Pharma's overall GF Score™ is 25/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Cocrystal Pharma (COCP), the current GF Score is 25 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cocrystal Pharma Business Description

Other Exchanges 8CC:Germany
Address 19805 North Creek Parkway, Bothell, WA, USA, 98011
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). The company has one reportable and operating segment dedicated to the research and development company's novel orally administered antiviral influenza candidate. The company has pipeline products for diseases like : Influenza, Norovirus, Coronavirus, Respiratory Viruses, and Hepatitis C.
25GF Score

Get the complete analysis for COCP

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.04
Price